Home › Funds › ORBIMED ADVISORS LLC › BMY

ORBIMED ADVISORS LLC position in BMY

BRISTOL-MYERS SQUIBB CO · Health Care

ORBIMED ADVISORS LLC reported holding 925,000 shares of BMY (BRISTOL-MYERS SQUIBB CO) in its Q2 2026 13F filing — a position valued at US$53.3M, representing 1.07% of its reported portfolio and ranking #29 among its reported holdings. ORBIMED ADVISORS LLC has disclosed BMY holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

Latest position (Q2 2026)925.00K sh
Reported value held$53.30M
Portfolio Weight1.07%
First reportedQ4 2025
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How ORBIMED ADVISORS LLC's BMY position evolved

ORBIMED ADVISORS LLC first disclosed a stake in BMY in Q4 2025 at 775,000 shares (US$41.8M). The position peaked in Q1 2026 at 925,000 shares, worth US$56.1M. Across 3 filings, ORBIMED ADVISORS LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 925,000 shares valued at US$53.3M.

Quarter by quarter

QuarterSharesValueChange
Q4 2025 775.00K $41.80M New
Q1 2026 925.00K $56.10M Add
Q2 2026 925.00K $53.30M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BMY and 13F data

BMY (BRISTOL-MYERS SQUIBB CO) is a Health Care company. 28 other funds we track also report a position in BMY — the largest reported positions include Banque Cantonale Vaudoise (US$7.85B), Charles Schwab Investment Management (US$3.89B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$3.89B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BMY

All BMY fund holders →

FAQ

How long has ORBIMED ADVISORS LLC held BMY?

ORBIMED ADVISORS LLC has disclosed BMY holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

What is ORBIMED ADVISORS LLC's current position in BMY?

As of Q2 2026, ORBIMED ADVISORS LLC holds 925.00K shares of BMY (BRISTOL-MYERS SQUIBB CO), valued at $53.30M, representing 1.07% of its reported portfolio and ranking #29.

Has ORBIMED ADVISORS LLC been buying or selling BMY?

In the latest 13F filing (Q2 2026), ORBIMED ADVISORS LLC held unchanged its position in BMY. The position peaked in Q1 2026 at 925.00K shares.

Which other funds hold BMY?

Other major institutional holders of BMY include Banque Cantonale Vaudoise, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 28 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.